Glipizide 10 MG Oral Tablet
Semantic Scholar uses AI to extract papers important to this topic.
This study evaluated the effects on glycemic control of the addition of 2.5 mg glipizide GITS to metformin in patients with… Expand Evaluation of effects of glipizide gastrointestinal therapeutic system (GITS) administered once daily (AM or PM) and… Expand Objective To compare the blood glucose level and associated hypoglycemia risks by using insulin Glargine or human NPH both… Expand ObjectiveThis study compared persistence on and adherence to therapy with glipizide gastrointestinal therapeutic system (GITS… Expand OBJECTIVE
Epidemiological studies have implicated increased plasminogen-activated inhibitor 1 (PAI-1) as a marker or predictor of… Expand This study was designed to compare the pharmacokinetic and short‐term pharmacodynamic profile of extended‐release glipizide GITS… Expand The entrapment and retention of plasma low-density lipoproteins (LDL) by arterial proteoglycans (PG) is a process central to… Expand UNLABELLED
Glipizide is a second generation sulphonylurea agent that is available in a Gastrointestinal Therapeutic System (GITS… Expand